Patient perspectives on chemotherapy de-escalation in breast cancer.
Gabrielle Betty RocqueCourtney P WilliamsCourtney AndrewsTimothy C ChildersKimberly D WisemanKathleen D GallagherNadine TungAlan BalchValerie M LawhonStacey A IngramThelma BrownTara KaufmannMary L SmithAngela DeMicheleAntonio C WolffLynne I WagnerPublished in: Cancer medicine (2021)
Fear of recurrence is a common concern among breast cancer survivors and patient advocates, contributing to resistance to de-escalation clinical trial participation. Additional research is needed to understand how to engage patients in de-escalation trials.